General Interest 1789 Mutiny on the HMS Bounty Three

New Post Public Reply Private Reply Replies (0) Message Board
dw
197
General Interest
1789
Mutiny on the HMS Bounty

Three weeks into a journey from Tahiti to the West Indies, the HMS Bounty is seized in a mutiny led by Fletcher Christian, the master’s mate. Captain William Bligh and 18 of his loyal supporters were set adrift in a small, open boat, and the Bounty set course for Tubuai south of Tahiti.

In December 1787, the Bounty left England for Tahiti in the South Pacific, where it was to collect a cargo of breadfruit saplings to transport to the West Indies. There, the breadfruit would serve as food for slaves. After a 10-month journey, the Bounty arrived in Tahiti in October 1788 and remained there for more than five months. On Tahiti, the crew enjoyed an idyllic life, reveling in the comfortable climate, lush surroundings, and the famous hospitality of the Tahitians. Fletcher Christian fell in love with a Tahitian woman named Mauatua.

On April 4, 1789, the Bounty departed Tahiti with its store of breadfruit saplings. On April 28, near the island of Tonga, Christian and 25 petty officers and seamen seized the ship. Bligh, who eventually would fall prey to a total of three mutinies in his career, was an oppressive commander and insulted those under him. By setting him adrift in an overcrowded 23-foot-long boat in the middle of the Pacific, Christian and his conspirators had apparently handed him a death sentence. By remarkable seamanship, however, Bligh and his men reached Timor in the East Indies on June 14, 1789, after a voyage of about 3,600 miles. Bligh returned to England and soon sailed again to Tahiti, from where he successfully transported breadfruit trees to the West Indies.

Meanwhile, Christian and his men attempted to establish themselves on the island of Tubuai. Unsuccessful in their colonizing effort, the Bounty sailed north to Tahiti, and 16 crewmen decided to stay there, despite the risk of capture by British authorities. Christian and eight others, together with six Tahitian men, a dozen Tahitian women, and a child, decided to search the South Pacific for a safe haven. In January 1790, the Bounty settled on Pitcairn Island, an isolated and uninhabited volcanic island more than 1,000 miles east of Tahiti. The mutineers who remained on Tahiti were captured and taken back to England where three were hanged. A British ship searched for Christian and the others but did not find them.

In 1808, an American whaling vessel was drawn to Pitcairn by smoke from a cooking fire. The Americans discovered a community of children and women led by John Adams, the sole survivor of the original nine mutineers. According to Adams, after settling on Pitcairn the colonists had stripped and burned the Bounty, and internal strife and sickness had led to the death of Fletcher and all the men but him. In 1825, a British ship arrived and formally granted Adams amnesty, and he served as patriarch of the Pitcairn community until his death in 1829.

In 1831, the Pitcairn islanders were resettled on Tahiti, but unsatisfied with life there they soon returned to their native island. In 1838, the Pitcairn Islands, which includes three nearby uninhabited islands, was incorporated into the British Empire. By 1855, Pitcairn’s population had grown to nearly 200, and the two-square-mile island could not sustain its residents. In 1856, the islanders were removed to Norfolk Island, a former penal colony nearly 4,000 miles to the west. However, less than two years later, 17 of the islanders returned to Pitcairn, followed by more families in 1864. Today, around 40 people live on Pitcairn Island, and all but a handful are descendants of the Bounty mutineers. About a thousand residents of Norfolk Island (half its population) trace their lineage from Fletcher Christian and the eight other Englishmen.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading